Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.46 | -$0.46 | -$0.46 |
Q2 2024 | 1 | -$0.40 | -$0.40 | -$0.40 |
Q3 2024 | 1 | -$0.39 | -$0.39 | -$0.39 |
Unity Biotechnology, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-0.38 earnings per share for the quarter, topping analysts' consensus estimates of $-0.4 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Unity Biotechnology, Inc. has generated $-3 earnings per share over the last year ($-2.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.77. Unity Biotechnology, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/04/2024 | Q3 2024 | -$0.40 | -$0.38 | 0.02 | $0 | $0 |
08/06/2024 | Q2 2024 | -$0.44 | -$0.31 | 0.13 | $0 | $0 |
05/14/2024 | Q1 2024 | -$0.34 | $0 | |||
04/15/2024 | Q4 2023 | -$0.48 | -$0.28 | 0.2 | $1.90 M | |
11/13/2023 | Q3 2023 | -$0.87 | -$1.05 | -0.18 | $0 | |
08/08/2023 | Q2 2023 | -$0.83 | -$0.85 | -0.02 | $0 | |
05/09/2023 | Q1 2023 | -$1.10 | -$0.84 | 0.26 | $0 | |
03/15/2023 | Q4 2022 | -$1.15 | -$0.97 | 0.18 | $-236,000 | |
11/08/2022 | Q3 2022 | -$0.99 | -$1.42 | -0.43 | $0 | |
08/12/2022 | Q2 2022 | -$2.80 | -$2.02 | 0.78 | $236,000 | |
05/10/2022 | Q1 2022 | -$2.60 | -$2.90 | -0.3 | $0 | |
03/15/2022 | Q4 2021 | -$3.10 | -$1.82 | 1.28 | $4.78 M | |
11/10/2021 | Q3 2021 | -$3.80 | -$2.97 | 0.83 | $0 | |
08/10/2021 | Q2 2021 | -$3.20 | -$3.25 | -0.05 | $0 | |
05/11/2021 | Q1 2021 | -$3.80 | -$2.91 | 0.89 | $0 | |
03/23/2021 | Q4 2020 | -$3.80 | -$3.68 | 0.12 | $0 | |
11/04/2020 | Q3 2020 | -$4.50 | -$5.25 | -0.75 | $0 | |
07/31/2020 | Q2 2020 | -$5.10 | -$3.76 | 1.34 | $0 | |
05/07/2020 | Q1 2020 | -$5.10 | -$5.90 | -0.8 | $0 | |
03/11/2020 | Q4 2019 | -$5.40 | -$3.92 | 1.48 | $105.50 M |
Unity Biotechnology, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates.
In the previous quarter, Unity Biotechnology, Inc. (:UBX) reported $-0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.4 by $0.02.
The conference call for Unity Biotechnology, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Unity Biotechnology, Inc.'s latest earnings report can be read online.
Unity Biotechnology, Inc. (:UBX) has a recorded net income of $0. Unity Biotechnology, Inc. has generated $-2.7 earnings per share over the last four quarters.
Unity Biotechnology, Inc. (:UBX) has a price-to-earnings ratio of -0.77 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED